scholarly journals A Novel Bayesian Framework For Multi-State Disease Progression Of Lung Cancer

2021 ◽  
Vol 12 (10) ◽  
pp. 3675-3680
Author(s):  
K. Karthikayani, Et. al.

CT screening has been commonly used to identify and diagnose lung cancer in its early stages. CT has been shown in clinical studies to reduce lung cancer mortality by 20% as compared to plain chest radiography; however, existing CT screening services face obstacles such as high over diagnosis rates, high costs, and elevated radiation exposure.The study develops computer and deep learning models for predictive lung cancer diagnosis and disease progression prediction in an effort to solve these difficulties. Using a symmetric chain code method and a machine learning system, a novel lung segmentation approach was first developed. The lung nodules connected to the lung wall are included in this process, which minimises over-segmentation error. Finally, to predict the inter disease progression of lung cancer, a Bayesian method was coupled with a prolonged Markov model.The resultant model calculates specific lung cancer state transition data, which can be used to make customised screening recommendations. Extensive trials and results have shown the efficacy of these approaches, paving the way for current CT screening systems to be optimised and improved.

2012 ◽  
Vol 136 (12) ◽  
pp. 1478-1481 ◽  
Author(s):  
Paul A. Bunn

Lung cancer is the leading worldwide cause of cancer deaths. Smoking is the dominant cause of lung cancer and smoking cessation is the established method to reduce lung cancer mortality. While lung cancer risk is reduced in former smokers, they have a lifelong increase in risk, compared to never-smokers. Novel chemoprevention strategies, such as oral or inhaled prostacyclin analogs, hold promise for these subjects. Low-dose spiral computed tomography screening reduced lung cancer mortality by 20% in high-risk heavy smokers older than 50 years. However, the high false-positive rate (96%) means that screened patients required controlled follow-up in experienced centers. An increasing percentage of patients with advanced lung cancer have molecular drivers in genes for which oral tyrosine kinase inhibitors have been developed.


2020 ◽  
Vol 47 (9) ◽  
pp. 4125-4136
Author(s):  
Noemi Garau ◽  
Chiara Paganelli ◽  
Paul Summers ◽  
Wookjin Choi ◽  
Sadegh Alam ◽  
...  

2019 ◽  
Vol 65 (12) ◽  
pp. 1508-1514 ◽  
Author(s):  
Xue Tang ◽  
Guangbo Qu ◽  
Lingling Wang ◽  
Wei Wu ◽  
Yehuan Sun

SUMMARY OBJECTIVE Lung cancer is the leading cause of cancer-related death. To reduce lung cancer mortality and detect lung cancer in early stages, low dose CT screening is required. A meta-analysis was conducted to verify whether screening could reduce lung cancer mortality and to determine the optimal screening program. METHODS We searched PubMed, Web of Science, Cochrane library, ScienceDirect, and relevant Chinese databases. Randomized controlled trial studies with participants that were smokers older than 49 years (smoking >15 years or quit smoking 10 or 15 years ago) were included. RESULTS Nine RCT studies met the criteria. LDCT screening could find more lung cancer cases (RR=1.58, 95%CI=1.25-1.99, P<0.001) and more stage I lung cancers (RR=3.45, 95%CI=2.08-5.72, P<0.001) compared to chest-X ray or the no screening group. This indicated a statistically significant reduction in lung-cancer-specific mortality (RR=0.84, 95%CI=0.75-0.95, P=0.004), but without a statistically reduction in mortality due to all causes (RR=1.26, 95%CI=0.89-1.78, P=0.193). Annually, LDCT screening was sensitive in finding more lung cancers. CONCLUSIONS Low-dose CT screening is effective in finding more lung cancer cases and decreasing the deaths from lung cancer. Annual low-dose CT screening may be better than a biennial screening to detect more early-stage lung cancer cases.


Lung Cancer ◽  
2012 ◽  
Vol 78 (3) ◽  
pp. 225-228 ◽  
Author(s):  
Takeshi Nawa ◽  
Tohru Nakagawa ◽  
Tetsuya Mizoue ◽  
Suzushi Kusano ◽  
Tatsuya Chonan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document